Docetaxel Injection: Your Optimal Solution for Advanced Cancer Treatment
ProcurenetShort description
Docetaxel Injection is a government-approved potent chemotherapeutic medication engineered for the management of severe cancers including but not confined to advanced or metastatic breast, head and neck, gastric, hormone-refractory prostate, and non-small cell lung cancer. Available dosage ranges encompass 20mg/1ml, 80mg/4ml, and 160mg/8ml, in addition to a 20mg/0.5ml single-dose vial in a two-vial formulation.
- Effective Treatment: Proven to deliver measurable results in diverse cancer types.
- Dosage Variation: Comes in multiple strengths for tailored treatment plans.
- Quality Assured: Manufactured with rigorous quality controls in place.
- Healthcare Administration: Administered by healthcare professionals to monitor possible side effects.
- Proper Handling: Strict adherence to storage guidelines to maintain drug efficacy.
-
Procurenet Team Tshim Sha Tsui
Hong Kong
3 years
Description
Docetaxel Injection: A Powerful and Versatile Chemotherapy Medication for Advanced Cancers
Addressing a multitude of malignancies, Docetaxel Injection offers a powerful therapeutic choice for physicians and patients dealing with cancer. It boasts a distinct mechanism of action that prevents cancer cells from proliferating, making it a highly effective agent in disease control and mitigation.
Unmatched Efficacy and Clinical Applications
- Docetaxel Injection is a widely recognized treatment option for several invasive cancer types such as metastatic breast cancer, head and neck cancer, gastric cancer, hormone-refractory prostate cancer, and non-small cell lung cancer.
- Endorsed by US FDA, it exhibits its efficacy and safety across diverse patient demographics and disease conditions, including neoplasms that are resistant to other chemotherapy medications.
- Diverse dosage options, including 20mg/1ml, 80mg/4ml, 160mg/8ml and 20mg/0.5ml single-dose vials, enable tailored treatment approaches based on patient's health status and disease stage.
- The drug’s global acceptance attests to its clinical effectiveness, with usage spanning North America, Europe, Australasia, Asia, Middle East, and Africa.
Administration and Safety Precautions
As a potent cytotoxic agent, Docetaxel Injection’s administration should be respected and confined to healthcare settings by qualified oncology professionals. Potential side effects may include neutropenia, hypersensitivity reactions, fluid retention, skin reactions, neurosensory reactions, and asthenia. Patients should be educated about these side effects before initiation of therapy. Dosage adjustments and careful patient monitoring are necessary to ensure minimal side effects and optimal therapeutic outcomes.
With its unique mechanism of action and worldwide clinical acceptance, Docetaxel Injection serves as a potent chemotherapeutic tool in cancer treatment, making significant contributions to improving patient survival and quality of life.
